Skip to main content
Contact Us
Subscribe
E-Edition
72°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Psychedelic/Assisted Therapies
Recent news which mentions Psychedelic/Assisted Therapies
< Previous
1
2
3
4
5
6
7
8
9
...
14
15
Next >
PharmAla's Australian JV Cortexa Orders First Commercial MDMA & Psilocybin Shipment
July 05, 2023
Tickers
PMBHF
Tags
Cannabis
Market News
Benzinga
From
Benzinga
Small Pharma Implements Costs Cut: New R&D Strategy And Management Team Change
July 05, 2023
Tickers
DMTTF
Tags
Management
News
Short/Acting Psychedelics
From
Benzinga
Awakn Life Sciences Sells London Clinics Business, Hopes To Divest Norwegian Unit Next
July 05, 2023
Tickers
AWKNF
Tags
Markets
Management
M&A
From
Benzinga
80% Of US Voters Support Easing Research Restrictions, Plus Other Insights From UC-Berkeley Poll
July 05, 2023
Tags
Exclusives
Markets
Guidance
From
Benzinga
Inside UC Berkeley's Nation-Representative Psychedelics Survey: Unveiling Unexpected Data
July 05, 2023
Tags
Imran Khan
Legal
National Survey
From
Benzinga
COMPASS Pathways Secures Up To $50M In Term Loan Facility With Hercules Capital
July 05, 2023
Tickers
ATAI
CMPS
HTGC
Tags
Small Cap
Psychedelics
treatment/resistant depression
From
Benzinga
Psyched: A $100M Donation Pledge, Frank Biden Gets Candid, New Search Trends & More
July 04, 2023
Tickers
BETRF
CYBN
DMTTF
DSNKY
Tags
SILO
PSIL
PHRRF
From
Benzinga
Harnessing The Power Of 5-MeO-DMT For Women Trauma Survivors: A Specialized Retreat
July 03, 2023
Tags
Tandava Retreats
Markets
Top Stories
From
Benzinga
All On Board For 5-MeO-DMT: This Retreat Hosts Expertly Guided Experiences For Women, BIPOC
July 02, 2023
Tags
Management
Interview
News
From
Benzinga
Small Pharma Implements Cost-Cutting Strategy To Reduce Cash Burn As Trial Progresses
June 29, 2023
Tickers
DMTTF
Tags
Psychedelics
News
DMT Entities
From
Benzinga
Reunion Neuroscience's Q4 And Full Year 2023 Financial Results, To Close Take-Private Deal In Q3
June 29, 2023
Tickers
MSSTF
REUN
Tags
Penny Stocks
Psychedelic/Assisted Therapies
Benzinga
From
Benzinga
This Biotech Is Entering The Clinical Stage With A Psilocin Analog Targeting Cluster Headaches
June 28, 2023
Tickers
LOBEF
Tags
LOBEF
Next/Generation Psychedelics
Psychedelics
From
Benzinga
BetterLife Fast Tracks Its US Patent For Non-Hallucinogenic Compound And Other LSD Derivatives
June 28, 2023
Tickers
BETRF
PHRRF
Tags
Next/Generation Psychedelics
Psychedelics
Market News
From
Benzinga
Cybin's FY2023 Financials, Guidance And Appointment Of Sanford R. Climan As Strategic Advisor
June 28, 2023
Tickers
CYBN
Tags
Markets
Guidance
Management
From
Benzinga
Ketamine News: PharmaTher Begins FDA Filing For KETARX Application, Stella Acquires Field Trip Assets
June 27, 2023
Tickers
FTHWF
PHRRF
Tags
News
Management
Markets
From
Benzinga
Japanese Pharma Company Sponsors Australian Start Up In Development Of Non-Hallucinogenic Medicines
June 27, 2023
Tickers
DSNKY
Tags
Market News
Cannabis
DSNKY
From
Benzinga
UK Greenlights Phase 2 Clinical Trial On Mindset Pharma's Psilocin Drug For Major Depression
June 27, 2023
Tickers
MSSTF
Tags
psilocybin therapies
Guidance
Markets
From
Benzinga
MindMed Shareholders Vote For All Six Company Nominees At Annual Meeting, Current R&D Path Upheld
June 27, 2023
Tickers
MNMD
Tags
Markets
Guidance
MNMD
From
Benzinga
$100M Investment & Donation To Psychedelics Research From Toms Shoes Founder Blake Mycoskie
June 27, 2023
Tags
Blake Mycoskie
News
Psychedelics
From
Benzinga
MDMA Deals: Optimi Supplies Numinus-MAPS Program & PharmAla Exports To Australian University
June 20, 2023
Tickers
NUMIF
OPTHF
PMBHF
Tags
Market News
Markets
Cannabis
From
Benzinga
Johns Hopkins Researchers Find Psychedelics Reopen The Social Reward Learning Period
June 19, 2023
Tags
Psychedelic/Assisted Therapies
Benzinga
Market News
From
Benzinga
CNN Goes Psychedelic: Anderson Cooper's Upcoming Show On Magic Mushrooms
June 16, 2023
Tickers
NFLX
Tags
CNN International
News
How To Change Your Mind
From
Benzinga
Awakn Life Sciences Announces Closing Of Second Tranche And Upsizing Of Previous Private Placement
June 15, 2023
Tickers
AWKNF
Tags
Markets
News
Psychedelics Financing
From
Benzinga
Nevada Governor Passes Psychedelics Bill To Form New Working Group And Future Regulated Access
June 15, 2023
Tags
Psychedelics Reform
News
Psychedelics
From
Benzinga
Federal Psychedelics: $75M Grant Program, NIDA's Special Interest In State & Local Reform
June 14, 2023
Tags
Veterans Psychedelics
Markets
Government
From
Benzinga
Canadian Financing: PharmAla Biotech Offers Non-Brokered Private Placement Up To $3.76M
June 13, 2023
Tickers
PMBHF
Tags
News
Management
PMBHF
From
Benzinga
Silo Pharma's New Ketamine Implant For Fibromyalgia And Chronic Pain Is In The Making
June 13, 2023
Tickers
SILO
TRYPF
Tags
Markets
News
SILO
From
Benzinga
Psyched: Dubai Psychedelics Event, Key Receptor Discovered, Drew Barrymore, Oprah's Guest, Swiss MDMA & More
June 13, 2023
Tickers
BETRF
BRAXF
COPHF
PSIL
Tags
Psychedelics Investing
PSIL
Market News
From
Benzinga
Wesana Shareholders Vote For Psilocybin And CBD Therapy Asset Sales To Lucy Scientific
June 12, 2023
Tickers
LSDI
WSNAF
Tags
Psychedelics
Contracts
Psilocybin program
From
Benzinga
Promising Milestone: FDA Approves California-Based Trial Assessing MDMA For Schizophrenia
June 12, 2023
Tickers
PMBHF
Tags
UCLA
Schizophrenia
Guidance
From
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
14
15
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.